Using eABR to improve hearing outcomes after vestibular schwannoma surgery
Simultaneous Translabyrinthine Surgery of Vestibular Schwannoma and Cochlear Implantation with Intraoperative EBERA and Correlation to Hearing Results - a Pilot Study
This study is testing if measuring brain responses during vestibular schwannoma surgery can help predict how well patients will hear after getting cochlear implants.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | Medical University of Vienna Academic / other |
| Locations | 1 site (Vienna, Austria) |
| Trial ID | NCT03745560 on ClinicalTrials.gov |
What this trial studies
This observational study involves patients undergoing simultaneous translabyrinthine vestibular schwannoma resection and cochlear implantation. It aims to correlate intraoperative eABR results with postoperative hearing outcomes. Patients will have eABR measurements taken before and after tumor resection, and their hearing performance with cochlear implants will be assessed using the Freiburger monosyllables test. The study seeks to categorize eABR responses into three groups to understand their relationship with hearing rehabilitation success.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 99 who are undergoing translabyrinthine vestibular schwannoma resection and are seeking hearing rehabilitation with a cochlear implant.
Not a fit: Patients who do not wish to participate in the study will not benefit from the findings.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of how eABR results can predict hearing outcomes, leading to better patient management and rehabilitation strategies.
How similar studies have performed: While the approach of correlating eABR results with hearing outcomes is not widely tested, similar studies have shown promise in improving patient outcomes in cochlear implantation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients between 18 and 99 years undergoing translabyrinthine vestibular schwannoma resection * Patients wanted hearing rehabilitation with a cochlear implant Exclusion Criteria: * patients who do not want to be part of the study
Where this trial is running
Vienna, Austria
- Akh, Muw — Vienna, Austria, Austria (Recruiting)
Study contacts
- Principal investigator: Christoph Arnoldner, MD — MUW, Allgemeines Krankenhaus
- Study coordinator: Valerie Dahm
- Email: valerie.dahm@meduniwien.ac.at
- Phone: 01/40400/33300
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.